1. Home
  2. RGEN vs CADE Comparison

RGEN vs CADE Comparison

Compare RGEN & CADE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • CADE
  • Stock Information
  • Founded
  • RGEN 1981
  • CADE 1876
  • Country
  • RGEN United States
  • CADE United States
  • Employees
  • RGEN N/A
  • CADE N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • CADE Major Banks
  • Sector
  • RGEN Health Care
  • CADE Finance
  • Exchange
  • RGEN Nasdaq
  • CADE Nasdaq
  • Market Cap
  • RGEN 6.5B
  • CADE 7.0B
  • IPO Year
  • RGEN N/A
  • CADE N/A
  • Fundamental
  • Price
  • RGEN $145.83
  • CADE $38.77
  • Analyst Decision
  • RGEN Buy
  • CADE Buy
  • Analyst Count
  • RGEN 11
  • CADE 11
  • Target Price
  • RGEN $167.90
  • CADE $40.00
  • AVG Volume (30 Days)
  • RGEN 929.7K
  • CADE 2.0M
  • Earning Date
  • RGEN 11-11-2025
  • CADE 10-20-2025
  • Dividend Yield
  • RGEN N/A
  • CADE 2.83%
  • EPS Growth
  • RGEN N/A
  • CADE N/A
  • EPS
  • RGEN N/A
  • CADE 2.82
  • Revenue
  • RGEN $673,956,000.00
  • CADE $1,744,915,000.00
  • Revenue This Year
  • RGEN $16.77
  • CADE $17.44
  • Revenue Next Year
  • RGEN $13.79
  • CADE $11.03
  • P/E Ratio
  • RGEN N/A
  • CADE $13.78
  • Revenue Growth
  • RGEN 8.73
  • CADE 42.82
  • 52 Week Low
  • RGEN $102.97
  • CADE $25.22
  • 52 Week High
  • RGEN $182.52
  • CADE $40.20
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 68.33
  • CADE 65.03
  • Support Level
  • RGEN $121.25
  • CADE $36.89
  • Resistance Level
  • RGEN $125.90
  • CADE $39.48
  • Average True Range (ATR)
  • RGEN 5.31
  • CADE 0.75
  • MACD
  • RGEN 2.79
  • CADE 0.06
  • Stochastic Oscillator
  • RGEN 84.15
  • CADE 69.81

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CADE Cadence Bank

Cadence Bank is a bank based in the United States. The operating segments are Corporate Banking segment focuses on C&I, business banking, and commercial real estate lending to clients in the geographic footprint, Community Banking segment provides a broad range of banking services through the branch network to serve the needs of community businesses and individual consumers in the geographic footprint, Mortgage segment includes mortgage banking activities of originating mortgage loans, selling mortgage loans in the secondary market and servicing the mortgage loans, Banking Services segment offers individuals, businesses, governmental institutions, and non-profit entities a widerange of solutions to help protect, grow, and transfer wealth, General Corporate and Other segment.

Share on Social Networks: